This Week in Cardiology

The top 5 studies from the recent American Heart Association meeting and the new cholesterol guidelines are discussed in this week's podcast.

16 Marras 201818min

ODYSSEY PCSK9 inhibitor trial in print, new bradycardia guidelines, echocardiography, and an AHA preview are the topics discussed in this week's podcast.

9 Marras 201813min

CV outcomes in patients with type 2 diabetes, canagliflozin, cardiorespiratory fitness, the value of randomized trials, and the most important paper of 2018 are reviewed in this week's podcast.

2 Marras 201816min

Oxygen supplementation, PCSK9 inhibitor pricing, rapid troponin testing, cardio-oncology and joint commission accreditation are discussed in this week's podcast.

26 Loka 201812min

Low-dose rivaroxaban for CAD/PAD, hypertension management in the community, research misconduct, cyber-security in cardiac devices, and bariatric surgery are discussed in this week's podcast.

19 Loka 201814min

Timing of aortic valve replacement, rivaroxaban failure post TAVR, statins beyond CVD, conflicts of interest, and post-stent antithrombotic management are discussed in this week's podcast.

12 Loka 201814min

The COAPT MitraClip trial, high dose omega-3 fatty acids, the VEST trial in print, renal denervation for resistant hypertension, and competing coronary stents are discussed in this TCT-heavy podcast.

28 Syys 201815min

ASA, polypharmacy, statins and obesity treatments are the topics discussed by Dr John Mandrola in this week's podcast

21 Syys 201815min